Return to content in this issue


Unsustained Response to Benralizumab in Eosinophilic Asthma After 3 Years of Therapy With Mepolizumab

Kurosawa M1, Shimizu Y2, Sutoh Y3, Sutoh E1,3

1Department of Allergy and Respiratory Medicine, Sutoh Hospital, Annaka, Gunma, Japan
2Division of Respiratory Medicine, Kaminakai Family Clinic, Takasaki, Gunma, Japan
3Department of Surgery, Sutoh Hospital, Annaka, Gunma, Japan

J Investig Allergol Clin Immunol 2021; Vol 31(4) : 353-355
doi: 10.18176/jiaci.0652

Key words: Anti-interleukin 5 therapy, Asthma Control Test, Blood eosinophil count, Eosinophilic asthma, FEV1